Foster Dykema Cabot & Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-111
Closed -$15.4K 437
2025
Q3
$15.4K Hold
111
﹤0.01% 320
2025
Q2
$15K Hold
111
﹤0.01% 270
2025
Q1
$16.2K Sell
111
-5,049
-98% -$733K ﹤0.01% 263
2024
Q4
$710K Hold
5,160
0.06% 65
2024
Q3
$795K Hold
5,160
0.07% 59
2024
Q2
$752K Sell
5,160
-254
-5% -$36.4K 0.07% 49
2024
Q1
$800K Sell
5,414
-131,214
-96% -$18.8M 0.07% 46
2023
Q4
$18.6M Buy
+136,628
New +$17.8M 1.97% 19

Other funds holding XLV

Foster Dykema Cabot & Partners's XLV Position: Q4 2025 in Review

Foster Dykema Cabot & Partners sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2025, closing a stake of 111 shares — an estimated $15.4K sold.

Foster Dykema Cabot & Partners first reported a position in XLV in Q4 2023 and held it in 8 quarters. The position peaked at $18.6M in Q4 2023. 1,832 funds tracked by Wall St. Rank hold XLV as of Q4 2025.

  • Foster Dykema Cabot & Partners reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2025 after selling out during the quarter.
  • Foster Dykema Cabot & Partners sold 111 State Street Health Care Select Sector SPDR ETF shares in Q4 2025, an estimated $15.4K.
  • Foster Dykema Cabot & Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2023 and held it in 8 quarters.
  • Foster Dykema Cabot & Partners's State Street Health Care Select Sector SPDR ETF position peaked at $18.6M in Q4 2023.
  • 1,832 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2025.

Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2025, filed 12 Feb 2026.